NCT00136214View on ClinicalTrials.gov

Cerebral Effects of Pegylated Interferon in Hepatitis C Positive Subjects

CompletedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

January 31, 2008

Study Completion Date

March 31, 2008

Conditions
Hepatitis C
Interventions
DIAGNOSTIC_TEST

MR brain and neuropsychiatric tests

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

Sponsors

Collaborators (1)

Schering-Plough
All Listed Sponsors
collaborator

Schering-Plough

INDUSTRY

lead

Beth Israel Deaconess Medical Center

OTHER

NCT00136214 - Cerebral Effects of Pegylated Interferon in Hepatitis C Positive Subjects | Biotech Hunter | Biotech Hunter